SC US (TTGP), LTD.SC US (TTGP), LTD.

Institutional investor · Portfolio as of Q4 2020

SEC EDGAR SourceSEC Filings

Top Holdings13 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

DOORDASH INC - A

52M$7.4B44.4%$140.200.00%
1 qtr
New
100

UNITY SOFTWARE INC

33M$5.1B30.2%$94.92+63.11%
2 qtrssince 2020-Q3
Unchanged
0
MDLAMDLADelisted

MEDALLIA INC

44.4M$1.5B8.8%
6 qtrssince 2019-Q3
Unchanged
0
PDDPDD
ADR

PDD HOLDINGS INC

5.3M$935.1M5.6%$24.80+622.22%
8 qtrssince 2019-Q1
Unchanged
0
CELLCELLDelisted

BERKELEY LTS INC

8M$719.6M4.3%
2 qtrssince 2020-Q3
Unchanged
0
BEKEBEKE
ADR

KE HOLDINGS INC-ADR

11M$674.8M4.0%$62.04-2.76%
2 qtrssince 2020-Q3
Unchanged
0

BRIDGEBIO PHARMA INC

2.5M$181M1.1%$26.97+163.66%
7 qtrssince 2019-Q2
Unchanged
0

AIRBNB INC-CLASS A

691,612$101.5M0.6%$146.800.00%
1 qtr
New
61
SUMOSUMODelisted

SUMO LOGIC INC

3.4M$97.3M0.6%
2 qtrssince 2020-Q3
Unchanged
0
DOYUDOYU
ADR

DouYu International Holdings Li

3.2M$35.1M0.2%

QUINCE THERAPEUTICS INC

1M$28.9M0.2%$42.51-32.65%
7 qtrssince 2019-Q2
Unchanged
0
EBEBDelisted

EVENTBRITE INC

42,102$762,0000.0%$17.49+4.63%
6 qtrssince 2019-Q3
Unchanged
0

BLOCK INC

2,857$622,0000.0%$74.97+194.83%
8 qtrssince 2019-Q1
Increased
27
$16.7B
AUM
13
Positions
Q4 2020
Filing
Rating · 3.5
Quarterly Portfolio Change
+42%Q2'19$1.5B+54%Q3'19$2.3B+3%Q4'19$2.3B-44%Q1'20$1.3B+695%Q3'20$10.4B+61%Q4'20$16.7B
Activity profile
$ moved · Q4'20
New63%Increased0%Decreased0%Exited37%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.1 quarters
<1Q23%1-4Q31%1-2Y46%2Y+0%

SC US (TTGP), LTD. manages $16.7B across 13 positions as of Q4 2020. Top holdings: DASH (44.4%), U (30.2%), MDLA (8.8%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 3.5/5.0.

Q4 2020 Summary

Added 3 new positions, exited 1, increased 1. Top move: DASH (NEW, conviction 100). Portfolio: $16.7B across 13 positions.

Top holdings by portfolio weight

Total AUM$17B
DASH44.38%
U30.22%
MDLA8.82%
PDD5.59%
CELL4.30%
BEKE4.03%
BBIO1.08%
ABNB0.61%
SUMO0.58%
DOYU0.21%
Other0.17%

Portfolio allocation by GICS sector

Sectors6
Consumer Cyclical50.58%
Technology30.23%
Unknown13.70%
Real Estate4.03%
Healthcare1.25%
Communication Services0.21%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Consumer Cyclical, Technology, Unknown
Compare DNA across all funds
7-dimension quality assessment
Strong(3.5 / 5.0)
Track Record51
Conviction39
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
FIGFIGFIGMA INC-CL A
Q1 2026 Q2 2026+1.5M shares-$460.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used